Actively Recruiting
Non Invasive Cancer Test (NICT): a Proof of Principle Study.
Led by Maastricht University Medical Center · Updated on 2025-10-07
40
Participants Needed
1
Research Sites
508 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators aim to collect tumor DNA out of blood of cancer patients. If this is successful this could lead to the development of a cancer test in blood in the future, which is less invasive than current diagnostic methods.
CONDITIONS
Official Title
Non Invasive Cancer Test (NICT): a Proof of Principle Study.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with newly diagnosed local or metastatic breast cancer, colorectal cancer, non-small cell lung cancer, or anaplastic glioblastoma before starting radiation therapy, chemoradiation, or chemotherapy
- Patients aged over 18 years
- Willing and able to follow the study protocol as judged by the investigator
- Signed informed consent provided
You will not qualify if you...
- History of malignant disease other than the cancer under study, except for adequately treated squamous cell carcinoma of the skin, basal cell carcinoma of the skin, or in situ cervix carcinoma
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maastricht University Medical Center
Maastricht, Limburg, Netherlands, 6229 HV
Actively Recruiting
Research Team
M
Merryn M. Macville, Dr.
CONTACT
J
Job J. Verdonschot, Drs.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here